BAYRY News and Press, Bayer AG ADR From 03/01/23

The European Commission has granted marketing authorization in the European Union (EU) for Orion's ( OTCPK:ORINY ) darolutamide, an oral androgen receptor inhibitor (ARi), plus androgen deprivation therapy (ADT) in combination with docetaxel, for the treatment of patients with m...

Summary Bayer delivered strong FY 2022 results, beating analyst consensus estimates with regards to both topline and earnings. However, markets punished the stock lower following the earnings release, due to a perceived weak 2023 outlook. But investors should consider that EPS proje...

Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) filed an application to Japan's Ministry of Health, Labor, and Welfare (MHLW) seeking approval of a high dose version, 8-mg, of the company's and Regeneron Pharmaceuticals' ( NASDAQ: REGN ) blockbuster drug Eylea (aflibercept) f...

Bayer AG (BAYZF) Q4 2022 Results Earnings Conference Call February 28, 2023, 08:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chairman, Chief Executive Officer and Chief Sustainability Officer Rodrigo Santos - President, Crop ...

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q4 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q4 - Results - Earnings Call Presentation

Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) Q4 earnings and sales were driven by Crop Science and Consumer Health but Pharmaceuticals saw a decline. Meanwhile, the company noted that it expects FY 2023 earnings to be below previous year due to inflation and price factors. Q4...

Bayer AG ( OTCPK:BAYZF ) has added activist Jeff Ubben to an independent, outside council of experts that advises the German chemicals and drug maker on sustainability. Ubben, who runs activist fund Inclusive Capital Partners and previously headed ValueAct, may not be satisfied with the p...

Summary GMO and Bridgewater recently published research notes that paint an unfavorable picture for US equities. According to GMO, US Large caps are forecast to return -1.6% after inflation over the coming 7-year period. Bridgewater Associates believes that the only way to slay infl...

Summary Bayer AG is a $50-billion multinational life sciences conglomerate based in Germany. The company is trading at a discount of at least 20% compared to its peers as well as to its historical multiples. 3 catalysts could reinvigorate the stock and unlock value: new management, ...

Summary Evogene's subsidiary Casterra has developed proprietary genomically modified, high-yield & high oil-content Castor seed varieties. In September 2022 the EU banned palm oil and soybean as a biofuel or biodiesel feedstock beginning 2023 through to 2030. Castor oil is a replace...